| A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease. | |
| | |
MedLine Citation:
|
PMID: 16584516 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: TSH receptor antibodies (TBII) in Graves' disease (GD) may be TSH receptor stimulating (TSAb) and blocking (TBAb) antibodies. In commercially available assays however, only total TBII titres can be measured, without discriminating between TSAb and TBAb. OBJECTIVE: To design a TBII bioassay to detect of TSAb and to correlate TSAb activity with severity of hyperthyroidism in de novo GD patients. PATIENTS: Thirty-five patients with de novo GD and 27 controls. METHODS: The JP-26-26 cell line, which constitutively expresses the TSH receptor (TSHR), was stably transfected with a cyclic adenosine monophosphate responsive element--luciferase construct. The clone B1 exhibited a near linear increase in luminescence from 0.2 mU/l to 50 mU/l bovine TSH and was used as a TBII bioassay. TBII, free T4 and TSH were measured in the sera of all patients and controls. RESULTS: In the sera of 35 GD patients, TBII titres did not correlate with serum free T4 concentrations. In contrast, a strong and highly significant correlation was found between TSHR stimulating activity (luminescence) as measured with the TBII bioassay and serum free T4 levels (R = 0.80, P < 0.001). Interestingly, the luminescence/TBII ratio had a wide range at low TBII titres, whereas high TBII titres were associated with a low degree of TSHR activation. The TBII bioassay also detected TBAb in GD patients who spontaneously developed hypothyroidism. CONCLUSIONS: The B1-TBII-bioassay as developed in our laboratory has a high sensitivity for the detection of TSAb in GD and predicts the severity of hyperthyroidism in untreated GD patients. In addition, we found that high TBII titres are associated with weak TSHR activation. |
| | |
Authors:
|
G C J Hovens; A M J Buiting; M Karperien; B E P B Ballieux; G van der Pluijm; A M Pereira; J A Romijn; J W A Smit |
Related Documents
:
|
2039996 - Changes in plasma lipid and lipoprotein cholesterol and weight prior to the diagnosis o... 6799076 - Serum retinol and the inverse relationship between serum cholesterol and cancer. 10952146 - X-ray diffraction study of human serum. 11925116 - Serum vascular endothelial growth factor and serum leptin in patients with cervical can... 20587406 - Clinical updates on egfr/her targeted agents in early-stage breast cancer. 11891526 - Evaluation of the malignant potential of aberrant crypt foci by immunohistochemical sta... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical endocrinology Volume: 64 ISSN: 0300-0664 ISO Abbreviation: Clin. Endocrinol. (Oxf) Publication Date: 2006 Apr |
Date Detail:
|
Created Date: 2006-04-04 Completed Date: 2006-07-24 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0346653 Medline TA: Clin Endocrinol (Oxf) Country: England |
Other Details:
|
Languages: eng Pagination: 429-35 Citation Subset: IM |
Affiliation:
|
Department of Endocrinology, Leiden University Medical Center, Leiden, Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antibodies, Blocking / blood Autoantibodies / blood* Biological Assay / methods Case-Control Studies Cell Line Female Graves Disease / blood* Humans Immunoglobulins, Thyroid-Stimulating / blood Luminescent Measurements Male Receptors, Thyrotropin / blood, immunology* Thyroid Hormones / blood* |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Blocking; 0/Autoantibodies; 0/Immunoglobulins, Thyroid-Stimulating; 0/Receptors, Thyrotropin; 0/Thyroid Hormones; 0/thyrotropin-binding inhibitory immunoglobulin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effects of growth reduction therapy using high-dose 17beta-estradiol in 26 constitutionally tall gir...
Next Document: Characterization of the metabolic phenotypes of Cushing's syndrome and growth hormone deficiency: a ...